P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL

Detalles Bibliográficos
Autores principales: Jain, N., Roboz, G., Konopleva, M., Liu, H., Schiller, G., Jabbour, E., Desai, P., Whitfield, D., Haider, A., Zernovak, O., Frattini, M., Brownstein, C., Larson, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429740/
http://dx.doi.org/10.1097/01.HS9.0000848660.69944.40
_version_ 1784779552781762560
author Jain, N.
Roboz, G.
Konopleva, M.
Liu, H.
Schiller, G.
Jabbour, E.
Desai, P.
Whitfield, D.
Haider, A.
Zernovak, O.
Frattini, M.
Brownstein, C.
Larson, R.
author_facet Jain, N.
Roboz, G.
Konopleva, M.
Liu, H.
Schiller, G.
Jabbour, E.
Desai, P.
Whitfield, D.
Haider, A.
Zernovak, O.
Frattini, M.
Brownstein, C.
Larson, R.
author_sort Jain, N.
collection PubMed
description
format Online
Article
Text
id pubmed-9429740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94297402022-08-31 P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL Jain, N. Roboz, G. Konopleva, M. Liu, H. Schiller, G. Jabbour, E. Desai, P. Whitfield, D. Haider, A. Zernovak, O. Frattini, M. Brownstein, C. Larson, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429740/ http://dx.doi.org/10.1097/01.HS9.0000848660.69944.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Jain, N.
Roboz, G.
Konopleva, M.
Liu, H.
Schiller, G.
Jabbour, E.
Desai, P.
Whitfield, D.
Haider, A.
Zernovak, O.
Frattini, M.
Brownstein, C.
Larson, R.
P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title_full P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title_fullStr P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title_full_unstemmed P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title_short P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
title_sort p1451: preliminary results from the flu/cy/alemtuzumab arm of the phase i balli-01 trial of ucart22, an anti-cd22 allogeneic car-t cell product, in patients with relapsed/refractory (r/r) cd22+ b-cell all
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429740/
http://dx.doi.org/10.1097/01.HS9.0000848660.69944.40
work_keys_str_mv AT jainn p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT robozg p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT konoplevam p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT liuh p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT schillerg p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT jabboure p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT desaip p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT whitfieldd p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT haidera p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT zernovako p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT frattinim p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT brownsteinc p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall
AT larsonr p1451preliminaryresultsfromtheflucyalemtuzumabarmofthephaseiballi01trialofucart22ananticd22allogeneiccartcellproductinpatientswithrelapsedrefractoryrrcd22bcellall

Ejemplares similares